Citation Impact
Citing Papers
Ketamine-Induced Loss of Phenotype of Fast-Spiking Interneurons Is Mediated by NADPH-Oxidase
2007 Science
Reactive oxygen species, toxicity, oxidative stress, and antioxidants: chronic diseases and aging
2023 Standout
Schizophrenia Synaptic Pathology and Antipsychotic Treatment in the Framework of Oxidative and Mitochondrial Dysfunction: Translational Highlights for the Clinics and Treatment
2023
The chemistry and biological activities of N-acetylcysteine
2013
N-Acetyl Cysteine as a Glutathione Precursor for Schizophrenia—A Double-Blind, Randomized, Placebo-Controlled Trial
2008
N-Acetyl Cysteine for Depressive Symptoms in Bipolar Disorder—A Double-Blind Randomized Placebo-Controlled Trial
2008
Gamma-band activity over early sensory areas predicts detection of changes in audiovisual speech stimuli
2005
Role of ROS and RNS Sources in Physiological and Pathological Conditions
2016 Standout
Oxidative stress as an etiological factor and a potential treatment target of psychiatric disorders. Part 2. Depression, anxiety, schizophrenia and autism
2015
Neural Synchrony in Brain Disorders: Relevance for Cognitive Dysfunctions and Pathophysiology
2006 Standout
Convergence of biological and psychological perspectives on cognitive coordination in schizophrenia
2003
The free-energy principle: a unified brain theory?
2010 Standout
Targeting oxidative stress in disease: promise and limitations of antioxidant therapy
2021 Standout
Reactive oxygen species: from health to disease
2012 Standout
Redox dysregulation, neurodevelopment, and schizophrenia
2009
Beyond the comparator model: A multifactorial two-step account of agency
2007 Standout
Perceptual Organization in Schizophrenia Spectrum Disorders: Empirical Research and Theoretical Implications.
2005
Nonparametric statistical testing of EEG- and MEG-data
2007 Standout
N-acetylcysteine for antioxidant therapy: pharmacology and clinical utility
2008
The efficacy of N-acetylcysteine as an adjunctive treatment in bipolar depression: An open label trial
2011
A preliminary, randomized, double-blind, placebo-controlled trial of l-carnosine to improve cognition in schizophrenia
2012
Antioxidant therapy for treatment of inflammatory bowel disease: Does it work?
2015 Standout
Oxidative stress in psychiatric disorders: evidence base and therapeutic implications
2008
Glutathione synthesis
2012 Standout
The promise of N-acetylcysteine in neuropsychiatry
2013
<p>Reactive Oxygen Species: Drivers of Physiological and Pathological Processes</p>
2020 Standout
A review on the oxidative and nitrosative stress (O&NS) pathways in major depression and their possible contribution to the (neuro)degenerative processes in that illness
2010 Standout
Antidepressant-like effects of N-acetyl-L-cysteine in rats
2008
AN fMRI EXAMINATION OF VISUAL INTEGRATION IN SCHIZOPHRENIA
2009
Existing and potential therapeutic uses for N-acetylcysteine: The need for conversion to intracellular glutathione for antioxidant benefits
2013
Whatever next? Predictive brains, situated agents, and the future of cognitive science
2013 Standout
Molecular Strategies for Targeting Antioxidants to Mitochondria: Therapeutic Implications
2014
Magnetic Resonance Spectroscopy Study of the Antioxidant Defense System in Schizophrenia
2010
Physiology and Pathophysiology of Carnosine
2013 Standout
Abnormal neural oscillations and synchrony in schizophrenia
2010 Standout
The Role of Oxidative Stress in Neurodegenerative Diseases
2015 Standout
Changes in EEG coherence during tests for nonverbal (Figurative) creativity
2007
Lateral thinkers are not so laterally minded: Hemispheric asymmetry, interaction, and creativity
2010 Standout
Glutathione dysregulation and the etiology and progression of human diseases
2009
Self-Monitoring in Schizophrenia
2007
Works of Pascal Vianin being referenced
Augmentation of induced visual gamma activity by increased task complexity
2003
Visual binding abilities in the initial and advanced stages of schizophrenia
2001
Glutathione Precursor, N-Acetyl-Cysteine, Improves Mismatch Negativity in Schizophrenia Patients
2007
A First Step Toward Cognitive Remediation of Voices: a Case Study
2006
Reduced P300 Amplitude in a Visual Recognition Task in Patients with Schizophrenia
2002
Reduced P300 Amplitude in a Visual Recognition Task in Patients with Schizophrenia
2002